Notably, almost 100% of colorectal cancer patients had BAZ1A detectable in tumor samples (Fig. 1A, red bar), with high BAZ1A immunopositivity in colon cancer tissue microarrays compared with normal colon samples (Fig. 1B). This evidence concerns the gene BAZ1A and neoplasm.